Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity.
Animals
HIV-1
/ immunology
Mice
HIV Antibodies
/ immunology
HIV Envelope Protein gp120
/ immunology
AIDS Vaccines
/ immunology
Protein Sorting Signals
Humans
Antibodies, Monoclonal
/ immunology
HIV Envelope Protein gp160
/ immunology
Antibodies, Neutralizing
/ immunology
Glycosylation
Mice, Inbred BALB C
Female
HIV Infections
/ immunology
HIV-1 envelope
HIV-1 vaccine
antibody-dependent cellular phagocytosis
antigenicity
glycosylation
immunogenicity
neutralization
signal peptide
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
06
08
2024
accepted:
09
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
9
10
2024
Statut:
epublish
Résumé
HIV-1 envelope (Env) is the key target for antibodies (Abs) against the virus and thus an important HIV-1 vaccine component. Env is synthesized from a gp160 precursor with a signal peptide (SP) at its N-terminus. This study investigated the influence of the SP on Env antigenicity and immunogenicity. Env proteins from two HIV-1 isolates, AA05 and AC02, were analyzed as gp120 and gp160 in their native wild-type (WT) forms and as chimeras with swapped SPs (AA05-02 and AC02-05). The WT and chimeric Env were assessed for antigenicity and glycosylation using monoclonal antibodies (mAbs) and glycan probes. Immunogenicity was tested in mice using three vaccine types: gp120 protein, gp120 DNA+gp120 protein, and gp120 DNA+gp160 DNA. The recombinant AC02 gp120 protein was antigenically superior to AA05 as indicated by higher reactivity with most mAbs tested. When SPs were swapped, the antigenicity of the chimeric gp120s (AA05-02 and AC02-05) resembled that of the gp120s from which the SPs were derived; AA05-02 was similar to AC02 and vice versa. Glycan probe reactivity followed a similar pattern: AA05-02 and AC02 showed similar affinity to high-mannose specific mAbs and lectins. Interestingly, the antigenicity of gp160s showed an opposite pattern; membrane-bound gp160 expressed with the AA05 SP (AA05 and AC02-05) showed greater mAb binding than gp160 with the AC02 SP (AC02 and AA05-02). Mice immunized with gp120 protein showed that AA05-02 induced stronger cross-reactive binding Ab responses than AA05 WT, and AC02 elicited stronger responses than AC02-05, indicating AC02 SP enhanced gp120 immunogenicity. However, when DNA vaccines were included (gp120 DNA+gp120 protein and gp120 DNA+gp160 DNA), the use of heterologous SPs diminished the immunogenicity of the WT immunogens. Among the three vaccine regimens tested, only gp120 DNA+gp160 DNA immunization elicited low-level Tier 2 neutralizing Abs, with AA05 WT inducing Abs with greater neutralization capabilities than AA05-02. These data demonstrate that the SP can significantly impact the antigenicity and immunogenicity of HIV-1 Env proteins. Hence, while SP swapping is a common practice in constructing Env immunogens, this study highlights the importance of careful consideration of the effects of replacing native SPs on the immunogenicity of Env vaccines.
Identifiants
pubmed: 39380992
doi: 10.3389/fimmu.2024.1476924
pmc: PMC11458420
doi:
Substances chimiques
HIV Antibodies
0
HIV Envelope Protein gp120
0
AIDS Vaccines
0
Protein Sorting Signals
0
Antibodies, Monoclonal
0
HIV Envelope Protein gp160
0
Antibodies, Neutralizing
0
gp120 protein, Human immunodeficiency virus 1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1476924Informations de copyright
Copyright © 2024 Upadhyay, Rao, Behzadi, Feyznezhad, Lambert, Kumar, Kumar, Yang, Jiang, Luo, Nadas, Arthos, Kong, Zhang, Hioe and Duty.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.